U.S. investigators: Contaminated heparin is global problem
Patient Safety Monitor: Global Edition, April 29, 2008
Investigators in the United States found that not only has contaminated blood thinner heparin caused dozens of U.S. deaths, but that it has affected 10 other countries, reports the L.A. Times.
Chinese officials doubt the claim that contamination occurred in the early stages of the drug's production on farms in China and urged for an inspection of Baxter Healthcare, a U.S. company that distributes heparin in the U.S., according to the Times.
The contaminant causes symptoms similar to allergic reactions. Imports of the drug from China have been banned in the U.S., reports the Times.
To read more, click here.
Comments
0 comments on “U.S. investigators: Contaminated heparin is global problem ”
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Answering service messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q&A: Coding for dry skin due to cold weather
- Q/A: Volume requirement for reporting hydration services
- Are your workforce members texting PHI?
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Privacy, security concerns high in HIEs
- QA:Coding multiple initial infusions
- OB services: Coding inside and outside of the package
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- HIPAA Q&A: Answering service messages
- HIPAA Q&A: TPO disclosures to a business associate
- Are your workforce members texting PHI?
- Q&A: Coding for dry skin due to cold weather
- Hospitalist-surgeon comanagement has no effect on outcomes
- Don't let these sentinel events trigger falsely
- Correctly bill ancillary bedside procedures in addition to the room rate
- Searched
